nach oben

Erschienen in:

01.01.2019 | Allergens (R. K. Bush & S. Vieths, Section Editors)

Microarray Immunodiagnostics for Aeroallergens

verfasst von: Enrico Heffler, Francesca Puggioni, Desideria Descalzi, Francesca Racca, Giorgio Walter Canonica, Giovanni Melioli

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The impact of new technologies, especially multiplexed molecular allergy diagnostics based on allergen arrays, on the management of complex patients with respiratory allergies has been important.

Recent Findings

Currently, the detailed characteristics of the IgE profile of the patient, such as sensitization to genuine or cross-reacting components or the sensitization to potentially harmful allergens, allow an allergist to tailor treatment in the context of precision medicine rules.

Summary

A number of relevant articles have been published in recent years on this topic, and, in this review, the new added values of allergen array-based diagnostics are reported.

Valenta R, Duchene M, Vrtala S, Birkner T, Ebner C, Hirschwehr R, et al. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol. 1991;88(6):889–94.CrossRef

Jahn-Schmid B, Harwanegg C, Hiller R, Bohle B, Ebner C, Scheiner O, et al. Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy. 2003;33(10):1443–9.CrossRef

• Canonica GW, et al. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol. 2018;18(1):51–8 In this article, the description of the differences between personalized medicine, mainly based on patient’s (clinical) endotype) and precision medicine, based on patient phenotype is used in the attempt to better focus pharmacological and immunological treatment of allergy. PubMed

Canonica GW, et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.CrossRef

Migueres M, Dávila I, Frati F, Azpeitia A, Jeanpetit Y, Lhéritier-Barrand M, et al. Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Transl Allergy. 2014;4:16.CrossRef

Warm K, Lindberg A, Lundbäck B, Rönmark E. Increase in sensitization to common airborne allergens among adults - two population-based studies 15 years apart. Allergy, Asthma Clin Immunol. 2013;9(1):20.CrossRef

Heffler E, Landi M, Quadrino S, Incorvaia C, Pizzimenti S, Vernero S, et al. Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Clin Mol Allergy. 2015;13:28.CrossRef

Nevis IF, Binkley K, Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy, Asthma Clin Immunol. 2016;12:20.CrossRef

• Kowalski ML, et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J. 2016;9(1):33 This is a relevant work describing the top-down approach of allergy diagnosisin great detail. CrossRef

10.

Melioli G, Compalati E, Bonini S, Canonica GW. The added value of allergen microarray technique to the management of poly-sensitized allergic patients. Curr Opin Allergy Clin Immunol. 2012;12(4):434–9.CrossRef

11.

Melioli G, Bonifazi F, Bonini S, Maggi E, Mussap M, Passalacqua G, et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem. 2011;44(12):1005–11.CrossRef

12.

• Heffler E, et al. Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis. World Allergy Organ J. 2018;11(1):7 In this work, the first description of the new allergen array-based diagnostic tool containing both extracts and component is presented. CrossRef

13.

Di Fraia, M., et al., A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study. Clin Exp Allergy, 2018.

14.

Williams P, Önell A, Baldracchini F, Hui V, Jolles S, el-Shanawany T. Evaluation of a novel automated allergy microarray platform compared with three other allergy test methods. Clin Exp Immunol. 2016;184(1):1–10.CrossRef

15.

Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods. 2014;66(1):106–19.CrossRef

16.

Melioli G, Passalacqua G, Canonica GW, Baena-Cagnani CE, Matricardi P. Component-resolved diagnosis in pediatric allergic rhinoconjunctivitis and asthma. Curr Opin Allergy Clin Immunol. 2013;13(4):446–51.CrossRef

17.

Riccio AM, et al. Molecular diagnosis and precision medicine in allergy management. Clin Chem Lab Med. 2016;54(11):1705–14.CrossRef

18.

Canonica GW, et al. Allergen immunotherapy (AIT): a prototype of precision medicine. World Allergy Organ J. 2015;8(1):31.CrossRef

19.

Ishizaka K, Ishizaka T. Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. J Allergy Ther. 1966;37(3):169–85.CrossRef

20.

Stanworth DR, et al. Specific inhibition of the Prausnitz-Kustner reaction by an atypical human myeloma protein. Lancet. 1967;2(7511):330–2.CrossRef

21.

Wide L, Bennich H, Johansson SG. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet. 1967;2(7526):1105–7.CrossRef

22.

Breiteneder H, Ferreira F, Reikerstorfer A, Duchene M, Valenta R, Hoffman-Sommergruber K, et al. Complementary DNA cloning and expression in Escherichia coli of Aln g I, the major allergen in pollen of alder (Alnus glutinosa). J Allergy Clin Immunol. 1992;90(6 Pt 1):909–17.CrossRef

23.

van der Veen MJ, van Ree R, Aalberse RC, Akkerdaas J, Koppelman SJ, Jansen HM, et al. Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. J Allergy Clin Immunol. 1997;100(3):327–34.CrossRef

24.

Douladiris N, Savvatianos S, Roumpedaki I, Skevaki C, Mitsias D, Papadopoulos NG. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases. Int Arch Allergy Immunol. 2013;162(2):163–72.CrossRef

25.

• Hemmer W, et al. ImmunoCAP cellulose displays cross-reactive carbohydrate determinant (CCD) epitopes and can cause false-positive test results in patients with high anti-CCD IgE antibody levels. J Allergy Clin Immunol. 2018;141(1):372–381 e3 In this article, the possibility of confounding effects caused by the solid-phase substrate on the specific IgE results is described. CrossRef

26.

Hiller R, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 2002;16(3):414–6.CrossRef

27.

•• Matricardi PM, et al. EAACI molecular allergology user’s guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1–250 This is a fundamental work for molecular allergist. In particular, the description of the first bottom-up approach in allergy diagnosis is introduced. CrossRef

28.

King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TAE, Thomas W. Allergen nomenclature. Allergy. 1995;50(9):765–74.CrossRef

29.

•• Mueller GA. Contributions and future directions for structural biology in the study of allergens. Int Arch Allergy Immunol. 2017;174(2):57–66 This is an article that should be fundamental for present and future molecular allergists for its structural biology approach to a clinical problem. CrossRef

30.

• Alessandri C, et al. Diagnosing allergic sensitizations in the third millennium: why clinicians should know allergen molecule structures. Clin Transl Allergy. 2017;7:21 A simple but appealing work explaining the basic mechanisms of allergy under the light of molecular components.CrossRef

31.

Passalacqua G, Melioli G, Bonifazi F, Bonini S, Maggi E, Senna G, et al. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy. 2013;68(8):1029–33.CrossRef

32.

Schmid-Grendelmeier P. Recombinant allergens. For routine use or still only science? Hautarzt. 2010;61(11):946–53.CrossRef

33.

Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol. 2007;119(4):826–30.CrossRef

34.

Prosperi MC, et al. Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach. Pediatr Allergy Immunol. 2014;25(1):71–9.CrossRef

35.

Melioli G, et al. Allergenius, an expert system for the interpretation of allergen microarray results. World Allergy Organ J. 2014;7(1):15.CrossRef

36.

Sastre J, Landivar ME, Ruiz-García M, Andregnette-Rosigno MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67(5):709–11.CrossRef

37.

Moreno C, Justicia JL, Quiralte J, Moreno-Ancillo Á, Iglesias-Cadarso A, Torrecillas M, et al. Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients. Allergy. 2014;69(10):1357–63.CrossRef

38.

Stringari G, Tripodi S, Caffarelli C, Dondi A, Asero R, di Rienzo Businco A, et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014;134(1):75–81.CrossRef

39.

Camacho, G.D., et al., How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children. Allergol Immunopathol (Madr), 2018.

40.

Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol. 2009;103(6):451–9 quiz 459–61, 495.CrossRef

Titel: Microarray Immunodiagnostics for Aeroallergens
verfasst von: Enrico Heffler
Francesca Puggioni
Desideria Descalzi
Francesca Racca
Giorgio Walter Canonica
Giovanni Melioli
Publikationsdatum: 01.01.2019
Verlag: Springer US
Erschienen in: Current Allergy and Asthma Reports / Ausgabe 1/2019
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI: https://doi.org/10.1007/s11882-019-0832-z

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Microarray Immunodiagnostics for Aeroallergens